Should I use Semax or Selank — and what's the difference between these two Russian nootropic peptides?

The short answer

Semax and Selank are the two most-used Russian nootropic peptides, frequently confused because they share an origin, a route (intranasal), and a research lineage. They do nearly opposite things.

Evidence tier: 3 for both — decades of Russian clinical use and a growing human-study base, with Western independent replication thinner than the Russian-language literature.

• Semax — stimulating. Focus, attention, cognitive endurance, mood support, neuroprotection.
• Selank — calming. Anxiety reduction without sedation, stress resilience.

They're complementary, not competing. Semax provides mental drive; Selank takes the edge off. Many users stack both for "calm focus." The decision is matching to your actual need.

For the broader cognitive-peptide picture see the Cognitive performance cornerstone.

Where they come from

Evidence tier: 2 — the shared Russian research lineage is well-documented.

Both Semax and Selank were developed in Russian pharmaceutical research and are approved medications there. Semax is a synthetic fragment of ACTH (with the hormonal activity removed); Selank is a synthetic analog of the immunomodulatory peptide tuftsin.

This shared origin is why they get grouped together and why the evidence has the same character — real Russian clinical use, growing human data, less Western independent replication than you'd want for full confidence. The Cognitive cornerstone covers this evidence-geography asymmetry in detail.

Semax — the stimulating one

Evidence tier: 3 — Russian clinical use + human studies; mechanism characterized.

Semax raises BDNF (brain-derived neurotrophic factor), modulates dopaminergic and serotonergic systems, and has neuroprotective effects (Medvedeva 2014).

What it does: - Improves focus and sustained attention - Supports cognitive endurance (long mental-work sessions) - Mood support / mild anti-depressant effect - Neuroprotection in ischemia/stress contexts

Profile: stimulating without the jitteriness or crash of caffeine or stimulant medications. Users describe a "clear focus" rather than a "wired" state. Onset within 15-30 minutes intranasally.

The catch: tolerance. The focus effect blunts with continuous daily use for many users, which is why cycling (5-on/2-off, or as-needed) is standard. See Semax nasal bioavailability for the route-specific detail.

Selank — the calming one

Evidence tier: 3 — Russian clinical use; anxiolytic trials.

Selank modulates GABAergic and serotonergic signaling and has immunomodulatory effects. Its defining property: anxiety reduction without sedation, dependence, or cognitive blunting (Zozulia 2008 anxiolytic trial).

What it does: - Reduces generalized anxiety - Improves stress resilience - Mild mood support - Immunomodulatory effects (a secondary property, less relevant to nootropic use)

Profile: calming without the sedation of benzodiazepines or the cognitive dulling. Users describe reduced anxiety while staying mentally sharp — the opposite of a benzo's "fuzzy calm." Onset within 15-30 minutes intranasally.

Selank's anxiolytic effect appears more durable than Semax's focus effect — less tolerance, though as-needed use is still typical. See Selank for anxiety for the deeper dive.

Head-to-head

Evidence tier: 3 — comparison grounded in each peptide's mechanism and clinical use.

• Primary effect — Semax: Focus / stimulation · Selank: Anxiety reduction / calm
• Mechanism — Semax: BDNF ↑, dopamine/serotonin modulation · Selank: GABA/serotonin modulation, immunomodulation
• Best for — Semax: Attention deficit, mental endurance, mood · Selank: Anxiety, stress, overstimulation
• Tolerance — Semax: Notable (cycle to preserve effect) · Selank: Lower (more durable)
• Route — Semax: Intranasal · Selank: Intranasal
• Onset — Semax: 15-30 min · Selank: 15-30 min
• Sedation — Semax: None (stimulating) · Selank: None (calm without sedation)
• Stackable — Semax: Yes — with Selank · Selank: Yes — with Semax

The shorthand: if your problem is not enough focus/drive, Semax. If your problem is too much anxiety, Selank. If both, stack them.

Using them together

Evidence tier: 3 — practitioner-evolved stacking; mechanistically complementary.

The Semax + Selank stack is common because the two peptides address complementary problems:

• Semax for focus and cognitive drive (morning / early day)
• Selank to manage anxiety or balance the Semax stimulation (as needed, or paired)

The combined effect many users seek is "calm focus" — the mental drive of Semax without the anxiety or overstimulation it can bring, smoothed by Selank. Neither achieves this alone.

Practical stacking: - Semax 2-3 sprays per nostril in the morning for focus - Selank as needed when anxiety rises or to take the edge off Semax - Both intranasal, so logistically simple to run together - Cycle the Semax (the tolerance-prone one); Selank can be more consistent

Dosing both

Evidence tier: 3 — practitioner-evolved dosing.

• Semax — Concentration: 0.1% (or 1% / NA-Semax) · Dose: 2-3 sprays/nostril · Frequency: 1-3× daily · Cycle: 5-on/2-off or as-needed
• Selank — Concentration: 0.1% (or NA-Selank) · Dose: 2-3 sprays/nostril · Frequency: As needed or 1-2× daily · Cycle: More flexible

Start low to gauge response, especially Semax which can over-stimulate at high doses. Effects within 15-30 minutes for both.

N-acetyl versions (NA-Semax, NA-Selank): modified for improved stability/bioavailability, possibly more potent. Evidence is thinner than for the base peptides. If using them, start lower.

Limitations

This is a comparison piece, not personalized medical advice.

• Anxiety and cognitive symptoms warrant medical evaluation — severe or persistent symptoms need a clinical workup, not just a peptide.
• Selank is not a substitute for established anxiety treatment if you have a diagnosed anxiety disorder.
• Semax can over-stimulate at high doses — start low.
• The Russian-source evidence asymmetry warrants calibrated confidence.
• Pregnancy and breastfeeding are contraindications.
• Vendor sourcing carries real safety risk for gray-market peptides. Verify via Finnrick.
• Marko Maal, MSc Pharmacy reviewed this article. Reviewer attribution does not constitute a doctor-patient relationship.

The bottom line

Semax and Selank do nearly opposite things despite their shared origin. Semax is stimulating — focus, attention, mental endurance. Selank is calming — anxiety reduction without sedation. Match to your need: focus deficit → Semax, anxiety → Selank, both → stack them for "calm focus." Cycle the Semax to preserve its effect; Selank tolerates more consistent use.

Related on this site

• Cognitive performance cornerstone
• Selank for anxiety
• Semax nasal bioavailability
• Nootropic peptide n=1 — cognitive metrics that aren't BS
• Cognitive peptides for ADHD and focus
• Main Semax peptide page
• Cognitive pillar hub
• Finnrick vendor testing

References

• Medvedeva EV, Dmitrieva VG, Povarova OV, et al. 2014. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain. Mol Biol (Mosk). 48(3):374-382. PMID 24532152 — Semax BDNF / mechanism.
• Zozulia AA, Neznamov GG, Siuniakov TS, et al. 2008. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 108(4):38-48. PMID 18577961 — Selank anxiolytic trial.
• Kost NV, Sokolov OY, Kurasova OB, et al. 2016. Semax and selank inhibit the enkephalin-degrading enzymes from human serum. Bioorg Khim. 42(5):592-595. PMID 28296072 — shared enzymatic mechanism of both peptides.
• Kolomin T, Shadrina M, Slominsky P, Limborska S, Myasoedov N. 2013. A new generation of drugs: synthetic peptides based on natural regulatory peptides. Neurosci Med. 4(4):223-252. — overview of Semax/Selank peptide-drug class.